Surviving syndemics - Authors' reply
- PMID: 34246345
- DOI: 10.1016/S0140-6736(21)01325-8
Surviving syndemics - Authors' reply
Conflict of interest statement
ELF has served on HIV prevention and treatment advisory boards for Gilead Sciences. RC has served on community advisory boards for ViiV Healthcare and Merck and has received grant funding from Gilead Sciences. DJM has served on a pre-exposure prophylaxis speakers' bureau for Gilead Sciences and an advisory board for ViiV Healthcare. EH and RAS declare no competing interests. Support for this Correspondence and the Lancet HIV in the USA Series was provided, in part, by amfAR, The Foundation for AIDS Research, The US National Institute on Drug Abuse, and The Desmond M Tutu Professorship in Public Health and Human Rights at Johns Hopkins University.
Comment on
-
Same script, different viruses: HIV and COVID-19 in US Black communities.Lancet. 2021 Mar 20;397(10279):1040-1042. doi: 10.1016/S0140-6736(20)32522-8. Epub 2021 Feb 19. Lancet. 2021. PMID: 33617773 No abstract available.
-
Surviving syndemics.Lancet. 2021 Jul 10;398(10295):118-119. doi: 10.1016/S0140-6736(21)01328-3. Lancet. 2021. PMID: 34246342 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
